← SynDRA
BUCLIZINE
SynDRA canonical compound SYN0023508 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | HRH1 |
|---|
| Mechanism of action | histamine receptor antagonist |
|---|
| Indication | migraine headache |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
- histamine receptor antagonist
Drug classes
- Histamine Agents
- Histamine Antagonists
- Neurotransmitter Agents
ATC classes
- R06A · ANTIHISTAMINES FOR SYSTEMIC USE
Cross-references
Synonyms
- buclifen
- histabuticine
- histabutizine
- histabutyzine
- hitabutyzyne
- buclizine hydrochloride
- buclizine HCl
- Buclizina
- Bucladin
- Buclifen
- Buclina
- Buclizinum
- Buclodin
- Histabuticine
- Histabutizine
- Histabutyzine
- Hitabutyzyne
- Posdel
- Softran
- Vibazine
- Aphilan R
- Buclizine dihydrochloride
- Buclizine hydrochloride
- Component of Softran
- Histabutyzine dihydrochloride
- Histabutyzine hydrochloride
- Vibazine hydrochloride
- AH 2526
- UCB 4445
- Aphilan-R base
- Buclina (TN)
- Buclizina [INN-Spanish]
- Buclizine (INN)
- Buclizine [INN:BAN]
- Buclizine, hydrochloride
- Buclizinum [INN-Latin]
- Component of Bucladin-S
- Migraleve (TN)
Look up BUCLIZINE in the interactive SynDRA portal →